APA (7th ed.) Citation

A, D., A, R., A, C., A, C., M, W., B, P., . . . JO, B. (2023). Faecal microbiota transplantation to prevent complications after allogeneic stem cell transplantation for haematological malignancies: A study protocol for a randomised controlled phase-II trial (the FMT-allo study). BMJ open, 13(5), e068480. https://doi.org/10.1136/bmjopen-2022-068480

Chicago Style (17th ed.) Citation

A, Dougé, Ravinet A, Corriger A, Cabrespine A, Wasiak M, Pereira B, Sokol H, Nguyen S, and Bay JO. "Faecal Microbiota Transplantation to Prevent Complications After Allogeneic Stem Cell Transplantation for Haematological Malignancies: A Study Protocol for a Randomised Controlled Phase-II Trial (the FMT-allo Study)." BMJ Open 13, no. 5 (2023): e068480. https://doi.org/10.1136/bmjopen-2022-068480.

MLA (9th ed.) Citation

A, Dougé, et al. "Faecal Microbiota Transplantation to Prevent Complications After Allogeneic Stem Cell Transplantation for Haematological Malignancies: A Study Protocol for a Randomised Controlled Phase-II Trial (the FMT-allo Study)." BMJ Open, vol. 13, no. 5, 2023, p. e068480, https://doi.org/10.1136/bmjopen-2022-068480.